Welcome to our dedicated page for AGBA Group Holding Ordinary Share news (Ticker: AGBA), a resource for investors and traders seeking the latest updates and insights on AGBA Group Holding Ordinary Share stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AGBA Group Holding Ordinary Share's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AGBA Group Holding Ordinary Share's position in the market.
AGBA Acquisition Limited (NASDAQ: AGBA) announced that shareholders approved all proposals regarding its business combination with TAG Holdings Limited during a special meeting on November 9, 2022. A total of 3,339,229 shares were tendered for redemption, with a final redemption price set at $11.617 per share. Stockholders have the option to withdraw their redemption requests until 12:00 p.m. Eastern Time on November 11, 2022. AGBA aims to merge with businesses primarily in healthcare, education, entertainment, and financial services sectors in China.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
AGBA Acquisition Limited has signed a business combination agreement with TAG Holdings Limited, including its subsidiaries. This deal values the Platform Businesses at US$555 million. AGBA plans to issue 55,500,000 ordinary shares at US$10.00 per share, with the combined entity expected to list on NASDAQ under the ticker AGBA. Post-combination, the company aims to have at least US$35 million net cash available. The strategic goal is to establish a leading personal wealth and health platform in the Greater Bay Area, leveraging existing infrastructure and technology.
Summary not available.
AGBA Acquisition Limited (NASDAQ: AGBA) announced it received a notice from Nasdaq on May 21, 2021, for not complying with Listing Rule 5250(c)(1) due to the delayed filing of its Form 10-Q for the March 31, 2021 quarter. The notice has no immediate effect on trading. The company is evaluating impacts from a recent SEC statement on warrants and aims to file the Form 10-Q promptly to regain compliance. AGBA has until July 27, 2021, to submit a compliance plan, with a potential extension to November 22, 2021.
Summary not available.
Summary not available.